Fig. 3.

Effect of dihydromyricetin on reduce the inflammatory response in BLM-treated mice. (A) Dosing regimen in BLM-induced inflammatory model. (B-C) H&E staining of left lung tissues (B, Scale: 50 μm) and inflammatory cells in BALF (C, Scale: 20 μm) of each group. (D) Total number of cells from BALF in each group. (E) Counts of macrophages in BALF. (F) Counts of lymphocytes in BALF. (G-I) The expression of inflammatory factors including IL-6, IL-1β and TNF-α in BALF were detected by ELISA. Data are shown as mean ± SD. # represent the difference between NaCl and BLM-treated group, ## p < 0.01, ### p < 0.001, #### p < 0.0001. * represent the difference between BLM-treated and treatment group, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.